Diabetes

Study of 12.6 million births shows 36 percent jump in gestational diabetes during the past decade

Discontinuing GLP-1 drugs early in pregnancy may raise risks of weight gain, diabetes, hypertension, and preterm delivery

With pregnancy supplement use at an all-time high, researchers say it’s time to revisit guidelines

Fully automated platforms and diagnostics partnerships are essential for clinical labs to manage increasing cardiometabolic test volumes

Julie Schulz, MD, MPH, discusses GLP-1 receptor agonists, the lab’s role in prescribing, and the future of the GLP-1 drug industry 

Curated resources on how testing methods and hemoglobin variants impact HbA1c accuracy—and what labs can do to ensure reliable results

Discover key insights into how automated HPLC systems provide reliable A1c results with detection of commonly occurring hemoglobin variants for optimum management of diabetes

Medway NHS Foundation Trust to transform local gestational diabetes screening by improving access to a new at-home diabetes testing technology

Two distinct signatures were detected in a subset of circulating, highly differentiated CD8-positive T cells in children at different stages of T1D

Increase in T2D research comes at time of rising interest in GLP-1s, including Ozempic and Wegovy